Mimix

logo_tagline
We provide a Point-Of-Care, cost efficient Tissue Engineering approach to regenerative, patient-tailored precision medicine. We focus on clinical indications performed in the operating theater by providing patient accessibility. At the heart of this revolutionary approach is a proprietary bio-processing technology: "Sound Induced Morphogenesis " - SIMmimiX biotherapeutics aims to deliver the next generation biofabrication technology, that will enable tissue manufacturing for therapeutic and diagnostic purposes. We will make this vision a reality by providing an ultra-fast biomanufacturing technology capable of creating Point-Of-Care patient specific biological tissue equivalents for regenerative, personalized and precision medicine. mimiX biotherapeutics’ technology has already demonstrated – with strong scientific evidence – that it offers tissue engineering strategies to overcome today’s obstacles, including the creation of dense networks of micro vascularization. Our technology is a game changer for regenerative medicine and diagnostics.

Profile Description

mimiX biotherapeutics aims to deliver the next generation biofabrication technology, that will enable tissue manufacturing for therapeutic and diagnostic purposes. We will make this vision a reality by providing an ultra-fast biomanufacturing technology capable of creating Point-Of-Care patient specific biological tissue equivalents for regenerative, personalized and precision medicine.

mimiX biotherapeutics’ technology has already demonstrated – with strong scientific evidence – that it offers tissue engineering strategies to overcome today’s obstacles, including the creation of dense networks of micro vascularization. Our technology is a game-changer for regenerative medicine and diagnostics.

CymatiX™: THE FIRST ACOUSTIC BIOPRINTER

Create biological architectures with sound

Sound Induced Morphogenesis (SIM) is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves.

This versatile method addresses necessities in the broad field of life sciences, finding application in tissue engineering, regenerative medicine, or pharmaceutical research for drug discovery.

With SIM, mimiX biotherapeutics offers the research community a novel R&D platform to complement and advance the existing biofabrication methodologies. SIM provides prospects to overcome some major limitations of conventional methods towards the creation of physiologically relevant in vitro models and engineered tissue constructs.

Leave a Comment

Time limit is exhausted. Please reload the CAPTCHA.

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec_
  • wp-settings-
  • wp-settings-time-

Decline all Services
Accept all Services

This information will not be shared with third parties